tradingkey.logo
搜尋

Rapid Micro Biosystems Inc

RPID
添加自選
2.070USD
-0.250-10.78%
收盤 05/15, 16:00美東報價延遲15分鐘
94.74M總市值
虧損本益比TTM

Rapid Micro Biosystems Inc

2.070
-0.250-10.78%

關於 Rapid Micro Biosystems Inc 公司

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

Rapid Micro Biosystems Inc簡介

公司代碼RPID
公司名稱Rapid Micro Biosystems Inc
上市日期Jul 15, 2021
CEOSpignesi (Robert)
員工數量163
證券類型Ordinary Share
年結日Jul 15
公司地址25 Hartwell Avenue
城市LEXINGTON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編02421
電話19783493200
網址https://www.rapidmicrobio.com/
公司代碼RPID
上市日期Jul 15, 2021
CEOSpignesi (Robert)

Rapid Micro Biosystems Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+12.88%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+37.05%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
29.44K
+2.86%
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. John Wilson
Mr. John Wilson
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kirk D. Malloy, Ph.D.
Dr. Kirk D. Malloy, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. James Xu
Mr. James Xu
Senior Vice President - Legal, Company Secretary
Senior Vice President - Legal, Company Secretary
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+12.88%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+37.05%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
29.44K
+2.86%
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Product revenue
23.43M
69.75%
Service revenue
10.16M
30.25%
地區USD
名稱
營收
佔比
United States
13.43M
39.99%
Switzerland
6.02M
17.92%
All other countries
5.77M
17.18%
Germany
5.77M
17.17%
Japan
2.60M
7.73%
業務
地區
業務USD
名稱
營收
佔比
Product revenue
23.43M
69.75%
Service revenue
10.16M
30.25%

股東統計

更新時間: 5月14日 週四
更新時間: 5月14日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Bain Capital Life Sciences Investors, LLC
20.44%
Kennedy Lewis Investment Management LLC
11.97%
Longitude Capital Management Co., LLC
8.62%
Endeavour Medtech Growth II LP
5.47%
Ally Bridge Group (HK) Limited
4.48%
其他
49.02%
持股股東
持股股東
佔比
Bain Capital Life Sciences Investors, LLC
20.44%
Kennedy Lewis Investment Management LLC
11.97%
Longitude Capital Management Co., LLC
8.62%
Endeavour Medtech Growth II LP
5.47%
Ally Bridge Group (HK) Limited
4.48%
其他
49.02%
股東類型
持股股東
佔比
Investment Advisor
37.20%
Venture Capital
9.88%
Investment Advisor/Hedge Fund
6.28%
Corporation
5.47%
Individual Investor
4.45%
Hedge Fund
3.07%
Private Equity
1.40%
Research Firm
0.54%
Pension Fund
0.06%
其他
31.65%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
67
25.08M
60.78%
+607.83K
2025Q4
59
23.36M
58.78%
-1.87M
2025Q3
56
23.72M
59.74%
-1.53M
2025Q2
68
28.04M
71.29%
+1.90M
2025Q1
76
27.59M
71.01%
+589.97K
2024Q4
81
24.48M
63.27%
-5.50M
2024Q3
105
26.74M
70.33%
-7.92M
2024Q2
116
27.58M
73.05%
-8.07M
2024Q1
141
28.00M
74.27%
-11.17M
2023Q4
153
28.87M
77.88%
-11.80M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Bain Capital Life Sciences Investors, LLC
8.43M
20.59%
--
--
Dec 31, 2025
Kennedy Lewis Investment Management LLC
4.94M
12.06%
--
--
Sep 30, 2024
Longitude Capital Management Co., LLC
4.08M
9.96%
-55.00K
-1.33%
Feb 03, 2026
Endeavour Medtech Growth II LP
2.26M
5.51%
--
--
Dec 31, 2025
Ally Bridge Group (HK) Limited
1.85M
4.51%
--
--
Dec 31, 2025
Spignesi (Robert G JR)
693.23K
1.69%
-17.92K
-2.52%
Mar 10, 2026
Advent International L.P.
577.78K
1.41%
--
--
Dec 31, 2025
Evernest Financial Advisors, LLC
125.00K
0.31%
-75.23K
-37.57%
Dec 31, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.02%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
佔比0.02%
Dimensional US Core Equity 1 ETF
佔比0%
Avantis US Small Cap Equity ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI